6651 - 6675 of 8801 Results
Title
Year
-
OPENTitle: Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case reportJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 36End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7085430Citation Count: 11
-
OPENTitle: The ZFHX3 GGC Repeat Expansion Underlying Spinocerebellar Ataxia Type 4 has a Common Ancestral FounderJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.30077Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30077Citation Count: 1
-
OPENTitle: Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patientsJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00348-yBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00348-yCitation Count: 8
-
OPENTitle: Decreased vestibular efficacy contributes to abnormal balance in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 440Issue #:Start Page: 120357End Page: 120357Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120357Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9444904Citation Count: 13
-
OPENTitle: Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error ratesJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 270Issue #: 12Start Page: 5813End Page: 5818Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-023-11810-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-023-11810-2.pdfCitation Count: 6
-
OPENTitle: A feed-forward pathway drives LRRK2 kinase membrane recruitment and activationJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.79771Best OA location URL: https://doi.org/10.7554/elife.79771Citation Count: 53
-
OPENTitle: Fidelity of frequency and phase entrainment of circuit-level spike activity during DBSJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 2Start Page: 825End Page: 834Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00259.2015Best OA location URL: http://doi.org/10.1152/jn.00259.2015Citation Count: 47
-
OPENTitle: Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association StudyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30054Best OA location URL: https://doi.org/10.1002/mds.30054Citation Count: 3
-
OPENTitle: T lymphocyte senescence is attenuated in Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12974-021-02287-9Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-021-02287-9Citation Count: 31
-
RESTRICTEDTitle: Detection of Proteolytic Signatures for Parkinson's DiseaseJournal Name: Future NeurologyPublisher: Informa UK LimitedVol: 11Issue #: 1Start Page: 15End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/fnl.16.3Citation Count: 0
- Differential effects of deep brain stimulation and levodopa on brain activity in Parkinson’s disease2020OPENTitle: Differential effects of deep brain stimulation and levodopa on brain activity in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaa005Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/1/fcaa005/33639744/fcaa005.pdfCitation Count: 23
-
RESTRICTEDTitle: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 1Start Page: 688End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6Citation Count: 56
- LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains2022OPENTitle: LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e3001427End Page: e3001427Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3001427Best OA location URL: https://doi.org/10.1371/journal.pbio.3001427Citation Count: 25
-
RESTRICTEDTitle: Parkinsonian monkeys with prior levodopa‐induced dyskinesias followed by fetal dopamine precursor grafts do not display graft‐induced dyskinesiasJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 525Issue #: 3Start Page: 498End Page: 512Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cne.24081Citation Count: 9
-
OPENTitle: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 17Start Page: 5625End Page: 5629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104Best OA location URL: http://doi.org/10.1016/j.bmcl.2012.06.104Citation Count: 149
-
OPENTitle: Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0282-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0282-4Citation Count: 203
-
OPENTitle: Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 12Start Page: 5765End Page: 5774Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1814909116Best OA location URL: https://www.pnas.org/content/pnas/116/12/5765.full.pdfCitation Count: 98
-
OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7939141Citation Count: 18
-
OPENTitle: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 120Issue #:Start Page: 107End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6422345Citation Count: 125
-
OPENTitle: Genome-wide association study of REM sleep behavior disorder in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01078-wBest OA location URL: https://www.nature.com/articles/s41531-025-01078-w.pdfCitation Count: 0
-
OPENTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: https://doi.org/10.1016/j.omtn.2022.02.007Citation Count: 21
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 11
-
RESTRICTEDTitle: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse modelsJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251Best OA location URL: https://doi.org/10.1016/j.omtn.2024.102251Citation Count: 3
-
OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 17
- Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism2024OPENTitle: Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanismJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91083.4Best OA location URL: https://doi.org/10.7554/elife.91083.4Citation Count: 0